Braunwald E. , Friedewald WT, Furberg CDProceedings of the workshop on platelet-active drugs in the secondary prevention of cardiovascular events. Circulation1980 ; 62: VI
2.
Hurst JW, Logue RB, Walter PFThe clinical recognition and management of coronary atherosclerotic heart disease. In: Hurst JW, Logue RB; Schlant RC, et al, eds. The heart, arteries, and veins. New York: McGraw-Hill, 1978:1216-1219
3.
Weinblatt E. , Shapiro S., Frank CW, et al. Prognosis of men after myocardial infarction: mortality and first recurrence in relation to selected parameters . Am J Public Health1968 ; 58: 1329-1347
4.
Kannel WG, Thomas HESudden coronary death: the Framingham study. Ann NY Acad Sci1982;382:3-21
5.
Beard OW, Hipp HR, Robins M., et al. Initial myocardial infarction among 503 veterans: five-year survival. Am J Med1960 ; 28: 871-883
6.
Cairns JA, Singer J., Gent M., et al. One year prognosis of CCU patients: complete follow-up from a community of 375,000 people. Circulation1985;72(suppl III):III-2
7.
Report from the Committee of Principal Investigators: a cooperative trial in the primary prevention of ischemic heart disease using clofibrate . Br Heart J1978 ; 40: 1069-1118
8.
Bigger JT Jr, Heller CA, Wenger TL, et al. Risk stratification after acute myocardial infarction. Am J Cardiol1978; 42:202-210
9.
Multicenter Participation Research Study. Risk stratification and survival after myocardial infarction. N Engl J Med1983; 309: 331-336
10.
Bigger JT Jr, Fleiss JL, Kleiger R., et al. The relationship among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation1984 ; 69: 250-258
11.
Davis HT, DeCamilla J., Bayer LW, et al. Survivorship patterns in the posthospital phase of myocardial infarction. Circulation1979;60:1252-1258
12.
Cairns JA, Fantus IG, Klassen GAUnstable angina pectoris. Am Heart1976;92:373-386
13.
Solomon HA, Edwards AL, Killip T.Prodromotor in acute myocardial infarction. Circulation1969;40:463
14.
Cairns JA, Gent M., Sackett D., et al. Coronary care utilization in Hamilton, Ontario (abstract). Ann R Coll Phys Surg Can1981;14:171
15.
Goldman L., Cook F., Hashimoto B., et al. Evidence that hospital care for acute myocardial infarction has not contributed to the decline in coronary mortality between 1973-1974 and 1978-1979. Circulation1982;65:936-942
16.
Lewis HD, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med1983;309:396
17.
Cairns JA, Gent M., Singer J., et al. A study of aspirin and/or sulfinpyrazone in unstable angina (abstract). Circulation1984;70:415
18.
Moise A., Theroux P., Taeymans Y., et al. Unstable angina and progression of coronary atherosclerosis . N Engl J Med1983;309:685-689
19.
Raffenbeul W., Smith LR, Rogers WJ, et al. Quantitative coronary arteriography. Coronary anatomy of patients with unstable angina pectoris re-examined 1 year after optimal therapy. Am J Cardiol1979;43:699-707
20.
Bertrand MEDiagnostic approach to unstable angina with coronary angiography. In: Hugenholtz PG, Goldman BS, eds. Unstable angina: current concepts and management . Stuttgart: Schattauer, 1985;119-125
21.
Hugenholtz PG , Michels HR, Surreys PW, et al. Nifedipine in the treatment of unstable angina, coronary spasm, and myocardial ischemia. Am Cardiol1981;47:163-173
22.
Vetrovec GW, Leinbach RC, Gold HK, Cowley MJIntracoronary thrombolysis in syndromes of unstable ischemia: angiographic and clinical results. Am Heart J1982 ; 104: 946-952
23.
Zack PM, Ischinger T., Aker UT, et al. The occurrence of angiographically detected intracoronary thrombus in patients with unstable angina pectoris. Am Heart J1984;108:1408-1411
24.
Capone GJ, Meyer BB, Wolf NM, Meister SGIncidence of intracoronary thrombi in patients with active unstable angina pectoris (abstract). Circulation1984;70(suppl II):II-415
25.
Cowley MJ, DiSciascio G., Vetrovec GWCoronary thrombus in unstable angina: angiographic observations and clinical relevance. In: Hugenholtz PG, Goldman BS, eds. Unstable angina: current concepts and management. Stuttgart: Schattauer, 1985;95-102
26.
Ambrose JA, Winters SL, Arora RR, et al. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol1986;7:472-478
27.
Wilson RF, Holida MD, White CWQuantitative angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina. Circulation1986; 73:286-293
28.
Maseri A., Cherchia S., L'Abbate A.Pathogenic mechanisms underlying the clinical events associated with atherosclerotic heart disease. Circulation1980;62(suppl V):V3-V13
29.
Maseri A., L'Abbate A., Baroldi G., et al. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med1978;299:1271-1277
30.
Sanz G., Castaner A., Betrui A., et al. Determinants of prognosis in survivors of myocardial infarction. A prospective clinical angiographic study. N Engl J Med1982;306:1065-1070
31.
DeWood MA, Spores J., Notske R., et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med1980;303:897-902
32.
Davies MJ, Thomas A.Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death . N Engl J Med1984;310:1137-1140
33.
Haft. JI. Role of blood platelets in coronary artery disease . Am J Cardiol1979;43:1197-1206
34.
Sobel M., Salzman EW, Daview GC, et al. Circulating platelet products in unstable angina. Circulation1981;63:300-305
35.
Neill WA, Wharton TP Jr, Fluri-Lundeen J., et al. Acute coronary insufficiency — coronary occlusions after intermittent ischemic attacks. N Engl J Med1980;302:1157-1162
36.
Page DL, Caulfield JB, Kastor JA, et al. Myocardial changes associated with cardiogenic shock. N Engl J Med1971; 285: 133-137
37.
Alonso DR, Scheidt S., Post MR, et al. Quantification of myocardial damage in cardiogenic shock. Circulation1973; 48:588
38.
Sobel BE, Bresnahan GF, Shell WE, et al. Estimation of infarct size in man and its relation to prognosis . Circulation1972;46:640
39.
Geltman EM, Ehsani AA, Campbell MK, et al. The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation1977 ; 60: 805-814
40.
Thompson PL , Fletcher EE, Kataratis V.Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction. Circulation1979;59: 113-119
41.
Bleifeld W. , Mathey D., Hourath P., et al. Infarct size estimated from serial serum phosphokinase in relation to left ventricular hemodynamics. Circulation1977;55:303
42.
Roberts R., Husain A., Ambos HD, et al. Relation between infarct size and ventricular arrhythmia. Br Heart J1975; 37: 1169-1175
43.
Rude RE, Muller JE, Braunwald E.Efforts to limit the site of myocardial infarcts. Ann Intern Med1981;95:736-761
44.
Reimer KA, Lowe JE, Rasmussen MM, et al. The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation1977 ; 56: 786-794
45.
Weinreich DJ , Burke JF, Pauletto FJLeft ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography . Ann Intern Med1984;100:789-794
46.
Falk E.Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarctions and/or peripheral embolization culminating in fatal vascular occlusions . Circulation1985;71:699-708
47.
Elwood PC, Cochrane AL, Burr ML, et al. A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J1974;1:436
48.
The Coronary Drug Project Research Group.Aspirin in coronary heart disease. J Chronic Dis1976;29:625
49.
Breddin K., Loew D., Lechner K., et al. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Hemostasis1980;9:325
50.
Elwood PC, Sweetnam PMAspirin and secondary mortality after myocardial infarction. Lancet1979;2:1313
51.
Aspirin Myocardial Infarction Study Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction . JAMA1980;243:661
52.
ThePersantine-Aspirin Reinfarction Study Research Group. Persantine and aspirin in coronary heart disease. Circulation1980 ;62:449
53.
Peto R.Editorial: aspirin after myocardial infarction. Lancet1980;1:1172
54.
TheAnturane Reinfarction Trial Research Group. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial . N Engl J Med1978;298:289
55.
TheAnturane Reinfarction Trial Research Group. Sulfinpyrazone in the prevention of sudden death after myocardial infarction. N Engl J Med1980;302:250
56.
Editorial.Sulfinpyrazone, cardiac infarction, and the prevention of death: a successful trial or another tribulation?Br Med J1978 ; 1:941-942
57.
Editorial.Sulfinpyrazone and prevention of myocardial infarction. Food and Drug Administration DrugBulletin1978;8:3
58.
Editorial. FDA says no to anturane. Science1980;208:1130
59.
Anturane Reinfarction Trial Policy Committee.The Anturane Reinfarction Trial: re-evaluation of outcome . N Engl J Med1982;306:1005-1008
60.
Report from the Anturane Reinfarction Italian Study: sulfinpyrazone in post-myocardial infarction. Lancet1982 ; 1: 237
61.
Klimt CR, Stamler J.Secondary coronary prevention with persantine and aspirin (abstract). J Am Coll Cardiol1985; 5:505
62.
Wright IS, Marple CD, Beck DFReport of the committee for the evaluation of anticoagulants in the treatment of coronary thrombosis with myocardial infarction. Am Heart J1948;36:801
63.
Assessment of short-term anticoagulant administration af ter cardiac infarction: report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council. Br Med J1969 ; 1: 335
64.
Drapkin A., Merskey C.Anticoagulant therapy after acute myocardial infarction: relation of therapeutic benefit to patient's age, sex and severity of infarction. JAMA1972;222: 541
65.
Anticoagulants in acute myocardial infarction: results of a cooperative clinical trial. JAMA1973;225:724
66.
Lovell RR, Denborough MA, Nestel PJ, et al. A controlled trial of long-term treatment with anticoagulants after myocardial infarction with 412 male patients. Med J Aust1967; 2:97
67.
MacMillan RL , Brown KW, Watt DLLong-term anticoagulant therapy after myocardial infarction. Can Med Assoc J1960; 83:567
68.
Meuwissen OJ , Vervoorn AC, Cohen O., et al. Double blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand1969;186:361
69.
Conrad LL, Kyriacopoulos JD, Wiggins CW, et al. Prevention of recurrences of myocardial infarction. A double-blind study of the effectiveness of long-term oral anticoagulant therapy. Arch Intern Med1964;114:348
70.
Wasserman AJ , Gutterman LA, Yoe KB, et al. Anticoagulants in acute myocardial infarction: the failure of anticoagulants to alter mortality in randomized series. Am Heart J1966;71:43
71.
Second report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council: an assessment of long-term anticoagulant administration after cardiac infarction. Br Med J1964 ; 2: 837
72.
United States Veterans Administration.Long-term anticoagulant therapy after myocardial infarction. JAMA1965;193:157
73.
Ebert RV, Borden CV, Hipp HR, et al. Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration cooperative study. JAMA1969;207:2263
74.
Breddin D., Loew D., Lechner K., et al. TheGerman-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. Circulation1980;62(suppl V):63
75.
International AnticoagulantReview Group. Collaborative analysis of long-term anticoagulant administration after acute myocardial infarction . Lancet1970;1:203
76.
Chalmers TC , Matta RJ, Smith H. Jr, et al. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med1977;297:1091
77.
Steffersen KACoronary occlusion treated with small doses of heparin. Acta Med Scand1969;186:519
78.
Hilden T., Iversen K., Raaschou F., et al. Anticoagulants in acute myocardial infarction. Lancet1961;2:237
79.
Modan B., Shani M., Schor S., et al. Reduction of hospital mortality from acute myocardial infarction by anticoagulant therapy. N Engl J Med1975 ;292:1359
80.
Tonascia J. , Gordis L., Schmerler H.Retrospective evidence favoring use of anticoagulants for myocardial infarction. N Engl J Med1975 ;292:1362
81.
Szklo M., Tonascia JA, Goldberg R., et al. Additional data favoring use of anticoagulant therapy in myocardial infarction: a population-based study. JAMA1979;242:1262
82.
Wessler S., Cornfield J.Coumarin therapy in acute myocardial infarction: a Hobson's choice. Arch Intern Med1974;134:774
83.
Carleton RA , Sanders CA, Burack WR, et al. Heparin administration after acute myocardial infarction. N Engl J Med1960;2:1002
84.
Ezekowitz MD , Kellerman DJ, Smith EO, et al. Detection of active left ventricular thrombosis during acute myocardial infarction using indium-III platelet scintigraphy . Chest1984; 86:35-39
85.
Johannessen KA, Nordrehaug JE, von der Lippe G.Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction. Br Heart J1984 ; 51: 553-556
86.
Keating EC, Gross SA, Schlamowitz RA, et al. Mural thrombi in myocardial infarctions. Prospective evaluation of two-dimensional echocardiography. Am J Med1983; 74:989
87.
Komrad MS, Coffey CE, Coffey KS, et al. Myocardial infarction and stroke. Neurology1984;34:1403
88.
Friedman MJ , Carlson K., Marcus FI, et al. Clinical correlations in patients with acute myocardial infarction and left ventricular thrombus detected by two-dimensional echocardiography. Am J Med1982;72:894
89.
Asinger RW, Mikell FL, Elsperger J., et al. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography . N Engl J Med1981;305:297-302
90.
Visser CA, Kan G., Lie KI, et al. Left-ventricular thrombus following acute myocardial infarction — a prospective serial echocardiographic study of 96 patients. Eur Heart J1983; 4: 333-337
91.
Stratton JR , Ritchie JL, Hamilton GW, et al. Left ventricular thrombi: in vivo detection by indium-III platelet imaging and two dimensional echocardiography . Am J Cardiol1981;47:874
92.
Ezekowitz MD , Wilson DA, Smith EO, et al. Comparison of indium-III platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricular thrombi. N Engl J Med1982;306:1509
93.
Marks P., Teather D.Subcutaneous heparin; a logical prophylaxis for deep vein thrombosis after myocardial infarction. The Practitioner1978 ;220:425
94.
Warlow C., Beattie AG, Terry G., et al. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet1973;2:934
95.
Handley Aj. Low-dose heparin after myocardial infarction. Lancet1972;2:623
96.
Nicolaides AN, Kakkar W., Renney Jtg, et al. Myocardial infarction and deep-vein thrombosis. Br Med1971;1:432
97.
Wray R., Maurer B., Shillingford J.Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction. N Engl J Med1973;288:815
98.
Handley AJ, Emerson PA, Fleming PRHeparin in the prevention of deep vein thrombosis after myocardial infarction . Br J Med1972;2:436
99.
Goldberg RJ , Gore JM, Dalen JE, Alpert JSLong-term anticoagulant therapy after acute myocardial infarction. Am Heart J1985 ; 109: 616-662
100.
β-Blocker Heart Attack Trial Research Group.A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results. JAMA1982;247: 1707-1714
101.
Norwegian Multicentre Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction . N Engl J Med1981 ; 304: 801-807
102.
Hjalmarson A., Herlitz J., Malek I., et al. Effect of mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial. Lancet1981;2:823-827
103.
Telford AM , Wilson C.Trials of heparin versus atenonol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet1981;1:1225-1228
104.
Stampfer MJ, Goldhaber SZ, Yusuf S., et al. Effect of intravenous streptokinase on acute myocardial infarction. Pooled results from randomized trials. N Engl J Med1982;307: 1180-1182
105.
Yusef S., Collins R., Peto R., et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side ef fects from 33 randomized controlled trials. Eur Heart J1985 ; 6: 556-585
106.
Boucek HJ, Murphy WPSegmental perfusion of the coronary arteries with fibrinolysis in veins following a myocardial infarction. Am J Cardiol1960 ;6:525
107.
Rentrop KP , Blanke H., Karsch KR, et al. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation1981;63:307
108.
Ganz W., Buchbinder N., Marcus H., et al. Intracoronary thrombolysis in evolving myocardial infarction . Am Heart J1981 ; 101:4
109.
Mathey DG, Kuck K-H., Tilsner V., et al. Non-surgical coronary artery recanolization in acute transmural myocardial infarction. Circulation1981;63:489
110.
Jutzy KR, Berte LE, Alderman EL, et al. Relation of systemic fibrinolytic state with route of streptokinase administration and recanalization. Circulation1983;68(suppl III):III-39
111.
Kennedy JW , Ritchie JL, Davis KB, Fritz JK: Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med1983;309:1477-1482
112.
Schroeder R., Biamino G., Leitner E-R., et al. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation1983;63:536-548
113.
Schroeder R.Systemic versus intracoronary streptokinase infusion in the treatment of acute myocardial infarction. J Am Coll Cardiol1983;1:1254—1261
114.
Pichard A. , Ziff C., Rentrop KP, et al. Incidence of total coronary occlusion in the chronic phase of myocardial infarction. Circulation1981;64(suppl IV):IV-107
115.
Betriu A., Castaner A., Sanz GA, et al. Angiographic findings 1 month after myocardial infarction: a prospective study of 259 survivors. Circulation1981;65:1099—1105
116.
Rentrop KP , Feit F., Blanke H., et al. Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion of coronary angiographic patterns and mortality in patients with acute myocardial infarction. N Engl J Med1984; 311:1457—1463
117.
Alderman EL , Jutzy KR, Berte LE, et al. Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarction. Am J Cardiol1984;54:14-19
118.
Valentine RP, Pitts DE, Brooks-Brunn JA, et al. Intravenous versus intracoronary streptokinase in acute myocardial infarction. Am J Cardiol1985 ; 55: 309-312
119.
TheISAM-Study Group. Intravenous streptokinase in acute myocardial infarction: preliminary results of a prospective controlled trial (I.S.AM.). Circulation1985;72(suppl III): III-223
120.
Gruppo Italiano per lo Studio della Streptokinase Nell'infarcto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet1986;1:397-402
121.
The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med1985;312:932-936
122.
Verstraete M., Borg M., Collen D., et al. Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet1985;1:842-847
123.
Collen D., Stump D., Van de Werf F., et al. Coronary thrombolysis in dogs with intravenously administered human pro-urokinase. Circulation1985;72:381-388
124.
Kasper W., Erbel R., Meinertz T., et al. Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction. J Am Coll Cardiol1984;4:357-363
